Article Figures & Data
Tables
- Table 1:
Demographic information of all patients undergoing myelography in 2016 at the 2 sites
Screened/Held Not Screened/Held Sex Male 81 78 Female 87 65 Age (yr) Median 58.5 57 Mean 57.4 ± 14 56.9 ± 12 Minimum 24 24 Maximum 87 85 Myelogram Cervical 34 40 Thoracic 1 3 Lumbar 121 61 Multilevel (>1 level) 12 39 Seizures 0 0 - Table 2:
Frequency of neurologic medications reported in patients undergoing myelography at the 2 sites
Medication Class Total Screened/Held Not Screened/Held Duloxetine SNRI 26 11 15 Sertraline SSRI 18 4 14 Venlafaxine SNRI 16 7 9 Bupropion Mixed 13 5 8 Trazodone Mixed 11 7 4 Amitriptyline TCA 10 2 8 Fluoxetine SSRI 10 3 7 Paroxetine SSRI 10 5 5 Citalopram SSRI 7 4 3 Escitalopram SSRI 6 3 3 Quetiapine Antipsychotic 4 2 2 Desvenlafaxine SNRI 3 0 3 Lurasidone Antipsychotic 2 1 1 Mirtazapine Mixed 1 0 1 Nortriptyline TCA 1 0 1 Amoxapine TCA 1 0 1 Imipramine TCA 1 1 0 Fluvoxamine SSRI 1 1 0 Risperidone Antipsychotic 1 1 0 Note:—SSRI indicates selective serotonin reuptake inhibitors; SNRI, serotonin and norepinephrine reuptake inhibitors.
Jump to section
Related Articles
Cited By...
- No citing articles found.